Prabhudas Lilladher Recommends 'BUY' for Max Healthcare, Sets Rs 1300 Target

• Prabhudas Lilladher maintains a 'BUY' rating for Max Healthcare Institute.
• Target price revised to Rs 1,300 per share.
• Q4 EBITDA growth was muted at 4% YoY due to seasonality and one-off events.
• Growth expected to improve from FY27 with new bed additions and CGHS price revisions.
• Operational efficiency remains commendable, especially in competitive markets like NCR.